Sentynl Therapeutics, Inc.

0 followers

‌

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Industries

Life Sciences, Therapeutics

Headquarters

Solana Beach, US

Employees

11-50

Links

Org chart

Matt Heck

Founder & CEO

Matt Heck

Collapse

Darren Pincus

Senior Vice President, Business Development

Grant Castor

Senior Vice President Commercial Strategy & Operations

Eileen Banaga

Vp, Regulatory Affairs And Quality

Michael Hercz

Senior Vice President, General Counsel & Chief Compliance Officer

Jennifer Reese

Senior Vice President & Head Of Medical Affairs

Mike Cvijanovich

Senior Director Of Rare Disease Marketing

Yvonne Breugelmans Mshrm

Director Of Human Resources And Payroll

Teams

Leadership Team

6 members

Commercial Strategy and Operations

4 members

Regulatory and Compliance

3 members

Similar companies

Curie.Bio

1 follower

Amgen

217 followers

Ecolab

75 followers

Phenomenex

1 follower

Sensitech

3 followers

Anthropic

61 followers

Earth Advantage

59 followers

Fortrea

6 followers

Atreides Management, LP

27 followers

Air

123 followers

Revvity

5 followers

Explore companies